Related Experiment Video
Updated: Dec 16, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.7K
Immune Microenvironment of Thyroid Cancer
Hongyu Yin1,2, Yemei Tang1,2, Yujia Guo1,2
1Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Shanxi Medical University, Taiyuan 030001, Shanxi, P.R. China.
Journal of Cancer
|July 7, 2020
Summary
Thyroid cancer (TC) research now highlights the crucial role of the immune microenvironment, moving beyond just tumor cells. Understanding immune cell interactions and checkpoints offers new avenues for TC prognosis and immunotherapy.
Area of Science:
- Endocrinology
- Oncology
- Immunology
Background:
- Thyroid cancer (TC) is a heterogeneous endocrine malignancy with higher incidence in women.
- Previous research focused on tumor cells, neglecting the tumor microenvironment's mesenchymal cells.
- Recent studies emphasize the interaction between thyroid cancer cells and peri-tumoral stroma.
Purpose of the Study:
- To comprehensively review the immune microenvironment in thyroid cancer.
- To explore immune cell roles, secreted mediators, and immune checkpoints in TC.
- To discuss immune evasion mechanisms and current immunotherapy strategies for TC.
Main Methods:
- Literature review of studies on thyroid cancer immunology.
- Analysis of immune cell components within the tumor microenvironment.
- Examination of immune evasion mechanisms and therapeutic approaches.
Main Results:
- Immune system components are closely linked to TC occurrence, invasion, and metastasis.
- The tumor microenvironment significantly influences treatment response and patient prognosis.
- Key immune cells, soluble mediators, and checkpoints in TC were identified.
Conclusions:
- The immune microenvironment is critical for thyroid cancer progression and patient outcomes.
- New strategies for TC prognosis prediction and immunotherapy can be developed.
- Targeting immune evasion mechanisms presents therapeutic opportunities for thyroid cancer.
Related Concept Videos
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
The Thyroid Gland
6.3K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.3K
Synthesis and Regulation of Thyroid Hormones
6.7K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.7K
Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K

